United States Healthcare Equipment & Supplies

MiMedx Group Inc (MDXG)

Track

The most recent insider trading activity at MiMedx Group Inc occurred on November 6, 2025, involving a sale of 58,300 shares by Chief Commercial Officer Kimberly Maersk-Moller. This follows a series of divestments by company executives throughout the year, contrasting with a significant purchase of 200,000 shares by the CEO in May 2025.
Ticker: MDXG Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for MiMedx Group Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 6 Nov 2025
Value US$1,875,312.35 | Price 200.65 | Shares 18,217 (+31.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-10 2025-11-06 S Sale
3.9
Maersk-Moller Kimberly

Chief Commercial Officer

Officer
18,217 +31.8%
200.65
US$1,875,312 		18,217 +31.8% 200.65 US$1,875,312
2025-11-06 2025-11-06 PrS Proposed sale
3.9
Kimberly Ann Maersk-Moller

Officer

Officer
76,562
227.38
US$2,446,167 		76,562 227.38 US$2,446,167
2025-05-05 2025-05-02 B Purchase
3.4
Capper Joseph H

Chief Executive Officer

Officer
55,835 -9.4%
299.50
US$4,517,032 		55,835 -9.4% 299.50 US$4,517,032
2025-03-20 2025-03-17 S Sale
3.9
Maersk-Moller Kimberly

Chief Commercial Officer

Officer
1,759 -0.6%
8.04
US$14,142 		1,759 -0.6% 8.04 US$14,142
2025-03-14 2025-03-13 S Sale
3.9
Maersk-Moller Kimberly

Chief Commercial Officer

Officer
4,106 -1.3%
7.89
US$32,396 		4,106 -1.3% 7.89 US$32,396
2025-03-14 2025-03-13 S Sale
3.8
Hulse William Frank IV

General Counsel and CAO

Officer
20,366 -4.4%
7.89
US$160,688 		20,366 -4.4% 7.89 US$160,688
2025-03-14 2025-03-13 S Sale
3.8
Hulse William Frank IV

General Counsel and CAO

Officer
34,230 -6.9%
7.89
US$270,075 		34,230 -6.9% 7.89 US$270,075
2025-03-12 2025-03-10 S Sale
3.8
Hulse William Frank IV

General Counsel and CAO

Officer
81,446 -14.1%
7.80
US$635,279 		81,446 -14.1% 7.80 US$635,279
2025-03-10 2025-03-10 PrS Proposed sale
3.8
Hulse William Frank IV

Officer

Officer
81,446
7.94
US$646,681 		81,446 7.94 US$646,681
2025-03-05 2025-02-28 S Sale
3.9
Maersk-Moller Kimberly

Chief Commercial Officer

Officer
2,111 -0.8%
8.41
US$17,743 		2,111 -0.8% 8.41 US$17,743
2025-02-18 2025-02-13 PlS Planned sale
2.8
Whitlow Ricci S

Chief Operating Officer

Officer
61,420 -13.2%
8.28
US$508,558 		61,420 -13.2% 8.28 US$508,558
2024-10-10 2024-10-10 PrS Proposed sale
GARDNER PHYLLIS

Former Director

Non-Executive Director
30,000
5.52
US$165,637 		30,000 5.52 US$165,637
2024-03-15 2024-03-13 S Sale
3.8
Hulse William Frank IV

General Counsel and CAO

Officer
20,381 -4.1%
7.95
US$162,029 		20,381 -4.1% 7.95 US$162,029
2024-02-21 2024-02-20 S Sale
2.8
Whitlow Ricci S

Chief Operating Officer

Officer
15,271 -3.7%
8.01
US$122,351 		15,271 -3.7% 8.01 US$122,351
2024-02-20 2024-02-20 PrS Proposed sale
2.8
Whitlow Ricci S

Officer

Officer
15,271
8.01
US$122,344 		15,271 8.01 US$122,344
2024-02-21 2024-02-16 S Sale
2.8
Whitlow Ricci S

Chief Operating Officer

Officer
15,493 -3.6%
8.07
US$125,075 		15,493 -3.6% 8.07 US$125,075
2024-02-16 2024-02-16 PrS Proposed sale
2.8
Whitlow Ricci S

Officer

Officer
15,493
8.07
US$125,077 		15,493 8.07 US$125,077
2024-02-16 2024-02-15 S Sale
2.8
Whitlow Ricci S

Chief Operating Officer

Officer
15,198 -3.4%
8.06
US$122,496 		15,198 -3.4% 8.06 US$122,496
2024-02-15 2024-02-15 PrS Proposed sale
2.8
Whitlow Ricci S

Officer

Officer
15,198
8.06
US$122,488 		15,198 8.06 US$122,488
2024-02-16 2024-02-14 S Sale
2.8
Whitlow Ricci S

Chief Operating Officer

Officer
15,845 -3.4%
8.03
US$127,267 		15,845 -3.4% 8.03 US$127,267
2024-02-14 2024-02-14 PrS Proposed sale
2.8
Whitlow Ricci S

Officer

Officer
15,845
8.03
US$127,275 		15,845 8.03 US$127,275
2023-11-22 2023-11-21 B Purchase
3.3
DOUG RICE

Chief Financial Officer

Officer
5,000 +5.1%
7.16
US$35,786 		5,000 +5.1% 7.16 US$35,786
2023-06-26 2023-06-23 B Purchase
3.4
Capper Joseph H

Chief Executive Officer

Officer
42,025 +72.5%
6.50
US$273,331 		42,025 +72.5% 6.50 US$273,331
2023-06-26 2023-06-22 B Purchase
3.4
Capper Joseph H

Chief Executive Officer

Officer
57,975 +inf%
6.33
US$367,103 		57,975 +inf% 6.33 US$367,103
2023-05-17 2023-05-16 S Sale
2.4
Stein Robert Benjamin

President, Regenerative Med.

Officer
10,365 -3.2%
5.95
US$61,627 		10,365 -3.2% 5.95 US$61,627
2023-05-16 2023-05-16 PrS Proposed sale
2.4
Stein Robert Benjamin

Officer

Officer
10,365
5.95
US$61,628 		10,365 5.95 US$61,628
2023-05-17 2023-05-15 S Sale
2.4
Stein Robert Benjamin

President, Regenerative Med.

Officer
3,607 -1.1%
6.15
US$22,170 		3,607 -1.1% 6.15 US$22,170
2023-05-15 2023-05-15 PrS Proposed sale
2.4
Stein Robert Benjamin

Officer

Officer
3,607
6.15
US$22,171 		3,607 6.15 US$22,171
2023-05-12 2023-05-10 S Sale
3.8
Hulse William Frank IV

General Counsel and CAO

Officer
5,870 -1.3%
5.93
US$34,786 		5,870 -1.3% 5.93 US$34,786
2023-05-12 2023-05-10 S Sale
2.8
Carlson Peter M

Chief Financial Officer

Officer
5,976 -0.9%
5.93
US$35,414 		5,976 -0.9% 5.93 US$35,414
2023-05-12 2023-05-10 S Sale
2.4
Stein Robert Benjamin

President, Regenerative Med.

Officer
5,869 -1.7%
5.93
US$34,780 		5,869 -1.7% 5.93 US$34,780
2023-05-12 2023-05-10 S Sale
2.1
Phelan William Lawrence

Chief Accounting Officer

Officer
1,595 -0.9%
5.93
US$9,452 		1,595 -0.9% 5.93 US$9,452
2023-05-10 2023-05-10 PrS Proposed sale
3.8
Hulse William Frank IV

Officer

Officer
5,870
5.93
US$34,786 		5,870 5.93 US$34,786
2023-05-10 2023-05-10 PrS Proposed sale
2.4
Stein Robert Benjamin

Officer

Officer
5,869
5.93
US$34,780 		5,869 5.93 US$34,780
2023-05-10 2023-05-10 PrS Proposed sale
2.8
Carlson Peter M

Officer

Officer
5,976
5.93
US$35,414 		5,976 5.93 US$35,414
2023-05-10 2023-05-10 PrS Proposed sale
2.1
Phelan William Lawrence

Officer

Officer
1,595
5.93
US$9,452 		1,595 5.93 US$9,452
2023-05-09 2023-05-04 S Sale
2.4
Stein Robert Benjamin

President, Regenerative Med.

Officer
51,756 -13.3%
5.34
US$276,470 		51,756 -13.3% 5.34 US$276,470
2023-05-04 2023-05-04 PrS Proposed sale
2.4
Stein Robert Benjamin

Officer

Officer
51,756
5.34
US$276,471 		51,756 5.34 US$276,471
2023-05-03 2023-05-02 S Sale
2.1
Phelan William Lawrence

Chief Accounting Officer

Officer
5,200 -2.7%
3.80
US$19,739 		5,200 -2.7% 3.80 US$19,739
2023-05-02 2023-05-02 PrS Proposed sale
2.1
Phelan William Lawrence

Officer

Officer
5,200
3.97
US$20,618 		5,200 3.97 US$20,618
2023-04-27 2023-04-25 S Sale
2.4
Stein Robert Benjamin

President, Regenerative Med.

Officer
5,987 -1.5%
3.74
US$22,415 		5,987 -1.5% 3.74 US$22,415
2023-04-27 2023-04-25 S Sale
2.1
Phelan William Lawrence

Chief Accounting Officer

Officer
1,628 -0.8%
3.74
US$6,095 		1,628 -0.8% 3.74 US$6,095
2023-04-27 2023-04-25 S Sale
2.8
Carlson Peter M

Chief Financial Officer

Officer
6,094 -0.9%
3.74
US$22,816 		6,094 -0.9% 3.74 US$22,816
2023-04-27 2023-04-25 S Sale
3.8
Hulse William Frank IV

General Counsel and CAO

Officer
5,988 -1.3%
3.74
US$22,419 		5,988 -1.3% 3.74 US$22,419
2023-04-25 2023-04-25 PrS Proposed sale
2.4
Stein Robert Benjamin

Officer

Officer
5,987
3.74
US$22,416 		5,987 3.74 US$22,416
2023-04-25 2023-04-25 PrS Proposed sale
3.8
Hulse William Frank IV

Officer

Officer
5,988
3.74
US$22,420 		5,988 3.74 US$22,420
2023-04-25 2023-04-25 PrS Proposed sale
2.8
Carlson Peter M

Officer

Officer
6,094
3.74
US$22,817 		6,094 3.74 US$22,817
2023-04-25 2023-04-25 PrS Proposed sale
2.1
Phelan William Lawrence

Officer

Officer
1,628
3.74
US$6,095 		1,628 3.74 US$6,095
2023-04-13 2023-04-11 S Sale
2.1
Phelan William Lawrence

Chief Accounting Officer

Officer
1,632 -0.8%
3.31
US$5,402 		1,632 -0.8% 3.31 US$5,402
2023-04-13 2023-04-11 S Sale
2.4
Stein Robert Benjamin

President, Regenerative Med.

Officer
5,996 -1.5%
3.31
US$19,847 		5,996 -1.5% 3.31 US$19,847
2023-04-13 2023-04-11 S Sale
2.8
Carlson Peter M

Chief Financial Officer

Officer
6,100 -0.9%
3.31
US$20,191 		6,100 -0.9% 3.31 US$20,191
2023-04-13 2023-04-11 S Sale
3.8
Hulse William Frank IV

General Counsel and CAO

Officer
5,995 -1.3%
3.31
US$19,843 		5,995 -1.3% 3.31 US$19,843
2023-04-11 2023-04-11 PrS Proposed sale
2.1
Phelan William Lawrence

Officer

Officer
1,632
3.31
US$5,404 		1,632 3.31 US$5,404
2023-04-11 2023-04-11 PrS Proposed sale
2.8
Carlson Peter M

Officer

Officer
6,100
3.31
US$20,197 		6,100 3.31 US$20,197
2023-04-11 2023-04-11 PrS Proposed sale
2.4
Stein Robert Benjamin

Officer

Officer
5,996
3.31
US$19,853 		5,996 3.31 US$19,853
2023-03-09 2023-03-07 S Sale
2.4
Stein Robert Benjamin

President, Regenerative Med.

Officer
12,355 -4.4%
4.24
US$52,442 		12,355 -4.4% 4.24 US$52,442
2023-03-09 2023-03-07 S Sale
3.8
Hulse William Frank IV

General Counsel and CAO

Officer
11,308 -3.2%
4.24
US$47,998 		11,308 -3.2% 4.24 US$47,998
2023-03-09 2023-03-07 S Sale
2.1
Phelan William Lawrence

Chief Accounting Officer

Officer
3,396 -2.3%
4.24
US$14,415 		3,396 -2.3% 4.24 US$14,415
2023-03-09 2023-03-07 S Sale
2.8
Carlson Peter M

Chief Financial Officer

Officer
12,056 -2.2%
4.24
US$51,173 		12,056 -2.2% 4.24 US$51,173
2023-02-24 2023-02-23 S Sale
2.8
Carlson Peter M

Chief Financial Officer

Officer
19,000 -3.4%
4.50
US$85,416 		19,000 -3.4% 4.50 US$85,416
2023-02-24 2023-02-23 S Sale
3.8
Hulse William Frank IV

General Counsel and CAO

Officer
15,555 -4.3%
4.53
US$70,477 		15,555 -4.3% 4.53 US$70,477
2022-12-27 2022-12-22 S Sale
2.8
Carlson Peter M

Chief Financial Officer

Officer
4,992 -0.9%
2.82
US$14,053 		4,992 -0.9% 2.82 US$14,053
2022-09-14 2022-09-13 S Sale
2.4
Stein Robert Benjamin

President, Regenerative Med.

Officer
8,329 -2.9%
3.46
US$28,785 		8,329 -2.9% 3.46 US$28,785
2022-09-14 2022-09-12 S Sale
2.4
Stein Robert Benjamin

President, Regenerative Med.

Officer
19,000 -6.2%
3.44
US$65,284 		19,000 -6.2% 3.44 US$65,284
2022-08-16 2022-08-12 S Sale
2.4
Stein Robert Benjamin

President, Regenerative Med.

Officer
8,503 -2.7%
4.04
US$34,344 		8,503 -2.7% 4.04 US$34,344
2022-08-11 2022-08-09 S Sale
3.6
Kashyap Rohit

President, WC & Surgical

Officer
12,343 -2.8%
4.21
US$51,939 		12,343 -2.8% 4.21 US$51,939
2022-08-08 2022-08-04 S Sale
2.4
Stein Robert Benjamin

President, Regenerative Med.

Officer
19,500 -5.8%
3.62
US$70,590 		19,500 -5.8% 3.62 US$70,590
2022-06-13 2022-06-09 S Sale
3.5
WRIGHT TIMOTHY R

Chief Executive Officer

Executive Director
112,000 -6.1%
3.75
US$420,000 		112,000 -6.1% 3.75 US$420,000
2022-05-10 2022-05-09 S Sale
2.9
Graves Mark

SVP & Chief Compliance Officer

Officer
3,891 -2.8%
3.50
US$13,622 		3,891 -2.8% 3.50 US$13,622
2022-05-10 2022-05-06 S Sale
2.1
Phelan William Lawrence

Chief Accounting Officer

Officer
5,750 -3.8%
3.81
US$21,908 		5,750 -3.8% 3.81 US$21,908
2022-05-04 2022-05-02 S Sale
3.4
Turner Scott M

SVP, Operations & Procurement

Officer
5,260 -2.3%
4.00
US$21,045 		5,260 -2.3% 4.00 US$21,045
2022-03-10 2022-03-08 S Sale
3.4
Turner Scott M

SVP, Operations & Procurement

Officer
4,155 -2.4%
4.86
US$20,189 		4,155 -2.4% 4.86 US$20,189
2022-03-10 2022-03-08 S Sale
2.1
Phelan William Lawrence

Chief Accounting Officer

Officer
3,268 -3.2%
4.86
US$15,879 		3,268 -3.2% 4.86 US$15,879
2022-03-10 2022-03-08 S Sale
2.9
Graves Mark

SVP & Chief Compliance Officer

Officer
3,234 -3.5%
4.86
US$15,714 		3,234 -3.5% 4.86 US$15,714
2022-03-10 2022-03-08 S Sale
2.8
Carlson Peter M

Chief Financial Officer

Officer
10,743 -2.7%
4.86
US$52,200 		10,743 -2.7% 4.86 US$52,200
Explore more

More insider trading research around MiMedx Group Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America